Quantification of Pathological Bias in the SignalomeLlevel Analyzing the Transcriptome-Wide Data
AbstractInvestigation of huge sets of transcriptomic data is commonly used now for gene expression profiling, e.g., of cancer patients with different tumor localization and morphology. Recently, we have proposes a method for aggregation of gene expression data into special subsets that may be used for characterization and quantification of pathological changes for individual patients at the level of virtually every known cell signaling pathway. The quantitative measure of relative pathological changes, whether it is over-activation or inhibition, of each signaling pathway, which we have suggested in our software packages OncoFinder] and GeroScope, accumulates the transcriotomic data according to the relative roles of different gene products in activation of signaling pathways.
Here, we test the abilities of our method to detect the meaningful information on the overall pattern of pathological changes for patients with malignant tumors. It is not a secret that the transcriptomic data does not always correlate well even for the same samples that were investigated using different methods and platforms. We gave performed a comparison of correlation coefficients between the data obtained using a RNA microarraying and RNA sequencing devices for three datasets of malignant cells. The results obtained shows that the aggregation of the transcriptomic data on the pool of genes into вЂњhigher-levelвЂќ sets that correspond to distinct signaling pathways can вЂњrestoreвЂќ the correlation between the mirroarray and RNA sequencing data, thus вЂњextractingвЂќ the meaningful signal from the transcriptome-wide вЂњnoiseвЂќ.
We also apply our method for pathway perturbation analysis to the search for markers of cancer types with different morphology and localization. The data pool were obtained the pool of data on gene expression levels on different cancer nosologic forms partly using the results our of own investigations of samples taken from the bladder carcinoma and various head and neck tumors, and partly using the information published in the Gene expression omnibus (GEO) repository. For each of eight nosologic forms that we have investigated using the pathway actiation strength (PAS) concept, we have found the specific pathway markers, as well as discriminators of one cancer type from another.
The journal Biomath Communications is an open access journal. All published articles are immeditely available online and the respective DOI link activated. All articles can be access for free and no reader registration of any sort is required. No fees are charged to authors for article submission or processing. Online publications are funded through volunteer work, donations and grants.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).